BUY Nephrocare Health Services — Axis Securities, 12 Oct 2026

BUYNephrocare Health Services Limited

Nephrocare Health Services share price target & all analyst calls

byAxis SecuritiesHorizon: NA (inferred 1 year)12 Oct 2026via Institutional / Brokerage Research

Entry₹619.55Inferred

Target₹750

Total upside +21.06%

Stop lossNot given

CMP₹617.1512h ago

Active-0.39%+21.53%upside left 12 mo left

Follow Axis Securities for new calls(71% target hit, 807 closed calls)Get alerts Watch NEPHROPLUS for new buy/sell callsGet alerts See 3 other Long-term calls on NEPHROPLUS See 133 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Oct, 4:35 am IST

12 supporting4 neutral4 opposing

Supports the BUY call (12)

India Ratings has upgraded Nephrocare Health Services Ltd's long-term bank loan facilities rating to 'IND AA-/Stable' from 'IND A+/Positive' and affirmed the short-term rating at 'IND A1+'. The upgrad

BSE · Company Update·18 Sept · 4w ago

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·8 Sept · 1mo ago

Neutral / worth noting (4)

Q2 FY27 results scheduled — board meets 03 Nov 2026

BSE · Board Meeting·In 19 days

Nephrocare Health Services Block Deal: Investors likely to sell 9% stake at ₹705/share

NewsCnbc-Tv18·24 Sept · 3w ago

Weighs against the BUY call (4)

Nephrocare shares tumble 5% | What’s driving the decline?

NewsLivemint·24 Sept · 3w ago

Nephroplus Block Deal: Investcorp, Bessemer, Promoters Likely To Offload Stake In Up To Rs 650-Crore Sale

NewsNdtv-Profit·23 Sept · 3w ago

Nephrocare Health Services Block Deal: Investors likely to sell 9% stake at ₹705/share

NewsCnbc-Tv18·23 Sept · 3w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Nephrocare Health Services

All analyst calls on Nephrocare Health Services

More from Axis Securities

Every call and its outcome

BUY Nephrocare Health Services Limited — Axis Securities

AI Assessment

Other calls on Nephrocare Health Services

More from Axis Securities